v3.25.2
Cover - shares
 3 Months Ended
Jun. 30, 2025
Aug. 11, 2025
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Jun. 30, 2025  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name Grace Therapeutics, Inc.  
Entity Central Index Key 0001444192  
Entity File Number 001-35776  
Entity Tax Identification Number 98-1359336  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --03-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 103 Carnegie Center Suite 300  
Entity Address, City or Town Princeton  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 08540  
Entity Phone Fax Numbers [Line Items]    
City Area Code 609  
Local Phone Number 322-1602  
Entity Listings [Line Items]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol GRCE  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   13,828,562